Assist. Prof. Dr. Simona Dedoni | Health Sciences | Research Excellence Award

Published on by Computer Scientists Awards

Assist. Prof. Dr. Simona Dedoni | Health Sciences | Research Excellence Award

Assistant Professor | University of Cagliari | Italy

Assist. Prof. Dr. Simona Dedoni is a researcher specializing in pharmacology, industrial biochemistry, and antiviral drug development, with a strong focus on molecular mechanisms of neurotoxicity and interferon-induced cellular responses. Her work contributes to understanding drug interactions, therapeutic pathways, and biomedical applications in disease treatment. She has established a significant scientific presence through high-impact publications and interdisciplinary research. According to Scopus data, she has 912 citations across 51 documents with an h-index of 19, reflecting strong academic influence, while her Google Scholar profile further indicates sustained citation growth and research visibility in pharmacological and biomedical sciences.

Citation Metrics

1000

800

600

400

200

0

 

Citations
912

Documents
51

h-index
19

                               ■ Citations
■ Documents
■ h-index


View Scopus Profile View ORCID Profile

Featured Publications

Prof. Wei Wu | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Prof. Wei Wu | Medicine | Best Researcher Award

Prof. Wei Wu | Director | Guangdong Provincial Institute of Public Health Guangdong Provincial Center for Disease Control and Prevention | China

Dr. Wei Wu is a distinguished public health scientist specializing in labor and environmental hygiene, microbial epidemiology, and health data analytics. His research primarily explores the intersection of gut microbiota, metabolic diseases, and public health, employing advanced population cohort and multi-omics data analysis to uncover novel biomarkers and disease risk genes. Dr. Wu’s studies contribute significantly to understanding nutrient–gut flora–host interactions, guiding innovative therapeutic targets for metabolic and infectious diseases. He has also made substantial contributions to vaccine health economics and hygiene assessment in rail transit systems. As a postgraduate supervisor and active member of multiple national scientific committees, Dr. Wu plays a vital role in shaping public health policy and research in China. His impactful scientific output has earned recognition in leading journals, including Nature Medicine and Microbiome. According to Scopus, he has published 35 documents with over 1,577 citations, an h-index of 13, and his work is widely cited across 1,498 documents. On Google Scholar, his publications have similarly received extensive academic engagement, underscoring his global research influence in environmental and preventive health sciences.

Publication Profile

Scopus | ORCID

Featured Publications

He, Y., Wu, W., Zheng, H. M., Li, P., McDonald, D., Sheng, H. F., et al. (2018). Regional variation limits applications of healthy gut microbiome reference ranges and disease models. Nature Medicine, 24(10), 1532–1535.

He, Y., Wu, W., Wu, S., Zheng, H. M., Li, P., Sheng, H. F., et al. (2018). Linking gut microbiota, metabolic syndrome and economic status based on a population-level analysis. Microbiome, 6(1), 172.

Guo, X., Yan, M., Huang, D., Chen, S., Zhang, D., Li, Z., Yang, X., & Wu, W. (2023). A large scale 16S ribosomal RNA gene amplicon dataset of hand, foot and mouth patients and healthy individuals. Scientific Data, 10(48), 1–6.

Yan, M., Guo, X., Ji, G., Huang, R., Huang, D., Li, Z., Zhang, D., Chen, S., Cao, R., Yang, X., & Wu, W. (2023). Mechanism-based role of the intestinal microbiota in gestational diabetes mellitus: A systematic review and meta-analysis. Frontiers in Immunology, 13(3), 1–13.

Wang, H., Luo, L., & Wu, W. (2023). SAS statistical analysis and applications from introduction to mastery (2nd ed.). Posts & Telecom Press.

Mrs. Yun Soobeen | Medicine | Best Researcher Award

Published on by Computer Scientists Awards

Mrs. Yun Soobeen | Medicine | Best Researcher Award

resident, Gachon University Gil Medical Center Dentistry, South Korea

Dr. Soobeen Yun is a dedicated dental professional currently serving as a Resident in the Department of Oral and Maxillofacial Surgery at Gachon University Gil Medical Center Dentistry 🇰🇷. With a strong academic foundation and a growing research portfolio, Dr. Yun is emerging as a promising figure in the field of oral surgery. Her passion for clinical excellence and academic inquiry is reflected in her involvement in advanced implantology research and case-based studies.

Publication Profile

ORCID

🎓 Education Background:

Dr. Yun completed her Doctor of Dental Surgery (D.D.S.) degree from Chosun University, College of Dentistry between 2016 and 2022 🎓. Her academic training laid a solid groundwork for her subsequent residency in oral and maxillofacial surgery, enabling her to combine theoretical knowledge with practical surgical experience.

💼 Professional Experience:

Currently, Dr. Yun holds a Resident position at Gachon University Gil Hospital in Incheon, South Korea 🏥, where she works in the Oral and Maxillofacial Surgery department. Her clinical duties are complemented by her active involvement in academic research, collaborative studies, and surgical innovation.

🏆 Awards and Honors:

Though early in her career, Dr. Yun’s scholarly work and professional promise are positioning her for recognition in her field 🌟. She has already contributed to reputable journal publications and continues to engage in research that improves surgical accuracy and patient outcomes, qualifying her as a strong candidate for emerging researcher awards.

🔬 Research Focus:

Dr. Yun focuses on guided implant surgery, maxillofacial trauma, and post-surgical rehabilitation using advanced techniques such as fibula free flaps 🦷🔍. Her current ongoing research is centered on evaluating the accuracy of guided implant surgery, contributing to improving the predictability and safety of oral surgical procedures.

🔚 Conclusion:

With a mix of clinical rigor, scholarly contributions, and an evolving research profile, Dr. Soobeen Yun exemplifies the qualities of a rising talent in oral and maxillofacial surgery 🥼📈. Her journey reflects commitment, innovation, and a deep desire to impact dental medicine through both hands-on care and academic excellence.

📚 Top Publications 

  1. 🔗 Errors in guided dental implant placement on inclined surfaces with fully-guided systems

    • 🗓 Published: 2025

    • 📘 British Journal of Oral and Maxillofacial Surgery

    • 📈 Cited by: 4 articles (as of latest data)

    • 🧠 Notes: This study highlights common error margins in implant placement when performed on sloped surfaces, guiding improvements in digital surgery protocols.

  2. 🔗 Mandibular Rehabilitation with Fibula Free Flap and Dental Implant: A 4-Year Follow–up

    • 🗓 Published: 2024

    • 📘 Journal of Implantology and Applied Sciences

    • 📈 Cited by: 2 articles

    • 🧠 Notes: This long-term follow-up study showcases the successful rehabilitation of mandibular defects using fibula free flap technique and subsequent dental implants.

  3. 🔗 Refracture at the same area after zygomaticomaxillary complex fracture surgery: a case report

    • 🗓 Published: 2023

    • 📘 Oral Biology Research

    • 📈 Cited by: 3 articles

    • 🧠 Notes: A rare case of post-operative refracture is detailed with clinical insights into surgical decisions and post-op patient management.

 

Prof. Jie Lu | Health Sciences | Best Scholar Award

Published on by Computer Scientists Awards

Prof. Jie Lu | Health Sciences | Best Scholar Award

Vice advisor, The Affiliated Hospital of Qingdao University, China

Dr. Jie Lu is a distinguished medical researcher and Associate Professor at The Affiliated Hospital of Qingdao University. With a strong background in internal medicine, endocrinology, and metabolism, Dr. Lu has made significant contributions to the field of hyperuricemia and gout research. His expertise in molecular and clinical studies has led to groundbreaking findings, including the development of a spontaneous hyperuricemia mouse model and critical insights into the relationship between hyperuricemia and metabolic disorders. His research has been widely recognized, earning him prestigious awards and global collaborations.

Publication Profile

🎓 Education

Dr. Jie Lu completed his MD and PhD in Internal Medicine from Qingdao University (2015-2018), following an MS in Endocrine and Metabolism (2012-2015) from the same institution. His academic journey began with a Bachelor’s in Medicine from Shandong Second Medical University (2007-2012), laying a strong foundation for his career in medical research.

👨‍🔬 Experience

Dr. Lu has been serving as an Associate Professor at The Affiliated Hospital of Qingdao University since 2022. Prior to this, he worked as a Research Fellow at the same institution (2018-2022), where he played a pivotal role in advancing hyperuricemia research. His international training experience spans institutions such as the University of Otago, Henry Ford Immunology Program in the USA, and the Chinese Academy of Sciences, enriching his expertise in bioinformatics, immunology, and molecular biology.

🏆 Awards and Honors

Dr. Lu’s excellence in medical research has been recognized through numerous prestigious awards. In 2022, he received the 13th Qingdao Youth Science and Technology Award. His contributions to scientific progress earned him the First Award of Shandong Province Science and Technology Progress in 2020. Throughout his academic career, he has been honored with multiple scholarships, including the National Graduate Scholarship (2017), Excellent Student Scholarship (2016-2017), and Freshman Scholarship (2015). His outstanding performance as a researcher and student has been acknowledged with multiple “Excellent Graduate” awards from Shandong Province and Qingdao University.

🔬 Research Focus

Dr. Lu’s research is dedicated to understanding the clinical and molecular mechanisms of hyperuricemia and gout. His pioneering work in constructing a spontaneous hyperuricemia mouse model has provided invaluable insights into disease progression and treatment strategies. His studies explore the relationship between hyperuricemia and renal function, diabetes, and arterial sclerosis, with high-impact publications in leading journals such as Nature Reviews Rheumatology, Kidney International, and Diabetes. He has also been instrumental in identifying the impact of COVID-19 vaccination on gout attacks, proposing colchicine as a preventive treatment.

🏁 Conclusion

Dr. Jie Lu is a leading researcher in hyperuricemia and gout, with a remarkable academic and research career. His extensive publications, international collaborations, and pioneering research have significantly contributed to the medical field. Recognized for his scientific achievements, Dr. Lu continues to make impactful discoveries that shape the future of metabolic disease treatment.

📚 Publications

Colchicine prophylaxis is associated with fewer gout flares after COVID-19 vaccination – Annals of the Rheumatic Diseases, 2022 🔗

Mouse models for human hyperuricaemia: a critical review – Nature Reviews Rheumatology, 2019 🔗

Knockout of the urate oxidase gene provides a stable mouse model of hyperuricemia associated with metabolic disorders – Kidney International, 2018 🔗

Hyperuricemia predisposes to the onset of diabetes via promoting pancreatic β-cell death in uricase-deficient male mice – Diabetes, 2020 🔗

Urate-lowering therapy alleviates atherosclerosis inflammatory response factors and neointimal lesions in a mouse model – The FEBS Journal, 2019 🔗

Superiority of low-dose benzbromarone to low-dose febuxostat in a prospective, randomized comparative effectiveness trial in gout patients with renal uric acid underexcretion – Arthritis Rheumatol, 2022 🔗

Metabolomics and Machine Learning Identify Metabolic Differences and Potential Biomarkers for Frequent Versus Infrequent Gout Flares – Arthritis Rheumatol, 2023 🔗

Profiling of Serum Oxylipins Identifies Distinct Spectrums and Potential Biomarkers in Young People with Very Early Onset Gout – Rheumatology (Oxford), 2023 🔗

Effects of fenofibrate therapy on renal function in primary gout patients – Rheumatology (Oxford), 2021 🔗

Trends in the manifestations of 9754 gout patients in a Chinese clinical center: A 10-year observational study – Joint Bone Spine, 2020 🔗